======= H2AFZ ======= == Gene Information == * **Official Symbol**: H2AZ1 * **Official Name**: H2A.Z variant histone 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3015|3015]] * **UniProt**: [[https://www.uniprot.org/uniprot/P0C0S5|P0C0S5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=H2AFZ&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20H2AFZ|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142763|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in the formation of constitutive heterochromatin. May be required for chromosome segregation during cell division. {ECO:0000269|PubMed:15878876}. |Histone| |Barr body| |nuclear heterochromatin| |nuclear euchromatin| |RNA polymerase II core promoter sequence-specific DNA binding| |cellular response to estradiol stimulus| |nucleosomal DNA binding| |nucleosome| |chromatin DNA binding| |RNA polymerase II distal enhancer sequence-specific DNA binding| |response to estradiol| |nuclear chromatin| |protein heterodimerization activity| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |chromatin organization| |response to lipid| |response to hormone| |response to organic cyclic compound| |cellular response to oxygen-containing compound| |chromosome organization| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |DNA binding| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-2.34| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.71| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.72| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.74| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.74| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.78| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.78| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.8| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.82| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.86| |[[:results:exp275|Citral 75μM R06 exp275]]|1.87| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.95| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.96| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.97| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|2.01| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|2.01| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.03| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|2.11| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|2.17| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|2.22| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|2.29| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|2.32| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.48| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.68| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|3.46| ^Gene^Correlation^ |[[:human genes:p:phf20|PHF20]]|0.491| |[[:human genes:s:srcap|SRCAP]]|0.433| |[[:human genes:m:mapkap1|MAPKAP1]]|0.432| |[[:human genes:h:hist1h2bk|HIST1H2BK]]|0.425| |[[:human genes:c:ccdc53|CCDC53]]|0.42| |[[:human genes:r:rictor|RICTOR]]|0.418| |[[:human genes:p:pgm3|PGM3]]|0.412| |[[:human genes:k:kdsr|KDSR]]|0.404| Global Fraction of Cell Lines Where Essential: 83/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|11/28| |bone|8/26| |breast|1/33| |central nervous system|3/56| |cervix|0/4| |colorectal|3/17| |esophagus|2/13| |fibroblast|0/1| |gastric|0/16| |kidney|2/21| |liver|1/20| |lung|7/75| |lymphocyte|6/16| |ovary|2/26| |pancreas|0/24| |peripheral nervous system|2/16| |plasma cell|3/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|6/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1371 * **Expression level (log2 read counts)**: 8.98 {{:chemogenomics:nalm6 dist.png?nolink |}}